649 related articles for article (PubMed ID: 18989125)
1. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
Calleja-Agius J; Brincat MP
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
3. [Hormone replacement therapy and the risk of developing breast cancer].
Merz WE
MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
[TBL] [Abstract][Full Text] [Related]
4. Where are we with postmenopausal hormone therapy in 2005?
Lam PM; Chung TK; Haines C
Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
[TBL] [Abstract][Full Text] [Related]
5. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
Sveinsdóttir H; Olafsson RF
J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
[TBL] [Abstract][Full Text] [Related]
6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL
J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
[No Abstract] [Full Text] [Related]
9. Women's health. The vanishing promises of hormone replacement.
Enserink M
Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
[No Abstract] [Full Text] [Related]
10. A personal initiative for women's health: to challenge the Women's Health Initiative.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
[No Abstract] [Full Text] [Related]
11. Indications for hormone therapy: the post-Women's Health Initiative era.
Reed SD; Newton KM; Lacroix AZ
Endocrinol Metab Clin North Am; 2004 Dec; 33(4):691-715. PubMed ID: 15501641
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
U.S. Preventive Services Task Force
Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Bittner V
Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
[TBL] [Abstract][Full Text] [Related]
15. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
Peeyananjarassri K; Baber R
Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
[TBL] [Abstract][Full Text] [Related]
17. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative.
Main P; Robinson M
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):861-8. PubMed ID: 18504768
[TBL] [Abstract][Full Text] [Related]
18. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
19. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
Leung KY; Ling M; Tang GW
Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
[TBL] [Abstract][Full Text] [Related]
20. Pitfalls of the WHIs: Women's Health Initiative.
Mastorakos G; Sakkas EG; Xydakis AM; Creatsas G
Ann N Y Acad Sci; 2006 Dec; 1092():331-40. PubMed ID: 17308158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]